Importantly, the development of experimental AIP depends on the activation of signaling pathways triggered by pDC-derived IFN-α and IL-33, since the depletion of pDCs or inhibition of IFN-α or IL-33-mediated signaling pathways effectively prevented the development of experimental AIP15,16. This evidence concerns the gene IFNA1 and autoimmune pancreatitis.